SEC Form 4 research
| Issuer | AgomAb Therapeutics NV |
|---|---|
| Tickers | AGMB |
| Reporting owners | 13 |
| Officers and directors | 3 |
| Last public filing | 2026-10-09 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-09 | 2026-10-08 | Epstein David R | P | 5,000 | $8.9 | Not reported |
| 2026-10-07 | 2026-10-06 | Epstein David R | P | 5,000 | $8.7 | Not reported |
| 2026-10-07 | 2026-10-05 | Epstein David R | P | 5,000 | $8.57 | Not reported |
| 2026-10-07 | 2026-10-06 | Kemula Pierre Thadee Victor | P | 2,000 | $8.54 | Not reported |
| 2026-10-07 | 2026-10-06 | Kemula Pierre Thadee Victor | P | 5,000 | $8.57 | Not reported |
| 2026-10-07 | 2026-10-06 | Kemula Pierre Thadee Victor | P | 3,000 | $8.67 | Not reported |
| 2026-10-07 | 2026-10-06 | Knotnerus Tim Jasper | P | 5,000 | $8.7 | Not reported |
| 2026-10-07 | 2026-10-05 | Knotnerus Tim Jasper | P | 6,000 | $8.48 | Not reported |
| 2026-09-15 | 2026-09-11 | Garcia Marino | A | 57,482 | $0 | Not reported |
| 2026-09-15 | 2026-09-11 | Patel Naimish | A | 56,328 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.